- Supplement No. 3 to Part 740—License Exception ENC Favorable Treatment Countries
Austria Australia Belgium Bulgaria Canada Croatia Cyprus Czech Republic Estonia Denmark Finland France Germany Greece Hungary Iceland Ireland Italy Japan Latvia Lithuania Luxembourg Malta Netherlands New Zealand Norway Poland Portugal Romania Slovakia Slovenia Spain Sweden Switzerland Turkey United Kingdom
[69 FR 71363, Dec. 9, 2004, as amended at 73 FR 57507, Oct. 3, 2008; 81 FR 64673, Sept. 20, 2016]